Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Q35571035)
Jump to navigation
Jump to search
scientific article published on 14 February 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia |
scientific article published on 14 February 2015 |
Statements
1 reference
Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (English)
1 reference
Hagop Kantarjian
1 reference
Jorge Cortes
1 reference
Tapan Kadia
1 reference
Susan O'Brien
1 reference
Farhad Ravandi
1 reference
Elias Jabbour
1 reference
Gautam Borthakur
1 reference
Guillermo Garcia-Manero
1 reference
Marina Konopleva
1 reference
Rebecca Garris
1 reference
Naval Daver
1 reference
Michael Rytting
1 reference
Deborah Thomas
1 reference
14 February 2015
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference